Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

171.52 +2.53 (+1.50%)
Official Closing Price Updated: 7:00 PM EDT, Jun 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,463,627
Open 169.99
Bid (Size) 169.42 (1)
Ask (Size) 171.52 (5)
Prev. Close 168.99
Today's Range 169.05 - 171.82
52wk Range 132.13 - 182.89
Shares Outstanding N/A
Dividend Yield 3.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Dividend Kings to Buy With Your Roth IRA Money in 2024
These seven Dividend Kings offer reliable income streams and long-term growth potential, making them ideal holdings for your Roth IRA. 
Via InvestorPlace
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
The FDA has approved Epkinly as the first subcutaneously administered bispecific antibody for adults with relapsed or refractory follicular lymphoma after two or more lines of prior therapy. 
Via Benzinga
Exposures Product Safety

Performance

YTD
+7.32%
+7.32%
1 Month
+10.81%
+10.81%
3 Month
-5.11%
-5.11%
6 Month
+10.68%
+10.68%
1 Year
+28.74%
+28.74%

More News

Read More
Looking At AbbVie's Recent Unusual Options Activity
Via Benzinga
Can AbbVie Stock Keep Outpacing the S&P 500?
Via The Motley Fool
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Check Out What Whales Are Doing With ABBV
Via Benzinga
AbbVie Stock Price Forecast: $200 On The Cards?
Via Talk Markets
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
Via Benzinga
AbbVie's Parkinson's Disease Therapy Hits FDA Roadblock
Via Benzinga
Exposures Product Safety
3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
Via The Motley Fool
Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income
Via InvestorPlace
AbbVie Inc. Dividend Stock Analysis - Saturday, June 22
Via Talk Markets
Week In Review: FutureGen Sells mAb For IBD To AbbVie In $1.7 Billion Deal
Via Talk Markets
Earn Income While Playing The Hottest Sectors
Via Talk Markets
3 Biotech Stocks to Buy Now: June 2024
Via InvestorPlace
Wall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for June 2024
Via InvestorPlace
Topics Retirement
Exposures Pension
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year
Via The Motley Fool
7 High-Value Blue-Chip Stocks to Boost Your Wealth by 2027
Via InvestorPlace
3 High-Dividend Stocks to Buy and Hold Forever: June 2024 Edition
Via InvestorPlace
2 Super Smart Dividend Stocks to Buy With $10,000 Right Now
Via The Motley Fool
Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades'
Via Benzinga
2 Dividend Stocks That Could Pay You for Life
Via The Motley Fool
7 A-Rated Biotech Stocks Worth Betting on in June
Via InvestorPlace
The Dividend Defenders: 3 Stocks That Will Protect and Grow Your Wealth Dividend Stocks
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.